Always discuss your treatment goals with your clinician, especially if youre using a GLP-1 to manage menopause-related weight changes
Pharmacy Practice in Focus: Health Systems May 2025 Volume 14 Issue 3 APhA 2025: GLP-1 Receptor Agonists vs SGLT2 Inhibitors Show Varied Benefit for Cardiovascular Outcomes in Patients With Diabetes Alana Hippensteele, Lead Editor Key Takeaways GLP-1 receptor agonists excel in stroke prevention, weight loss, and glycemic control, with significant reductions in major adverse cardiovascular events
Now, Im slowly titrating down to that range as I begin maintenance
Follow standard laboratory reconstitution and handling protocols
Examine the patients past medical history, especially regarding renal (kidneys) and hepatic (liver) functions, to ensure safe metabolism and excretion of infused liquids in the body
The imputation model was a linear regression of the endpoint with gender as factor and baseline value of the endpoint, timing and the value of last available observation on study (LAO-OS) of the endpoint as covariates, imputed by treatment status